Select a medication above to begin.
Iberdomide
iberdomide
Adult Dosing .
Dosage forms: PO
Investigational New Drug (IND)
- [pending FDA approval]
multiple myeloma, relapsed or refractory
- [indication/patient population pending FDA approval]
- Info: binds to cereblon protein, modulates cereblon E3 ligase complex, resulting in potent antitumor and immunomodulatory effects
Peds Dosing .
- Dosage forms: --
Investigational New Drug (IND)
- [pending FDA approval]
- Info: not anticipated to be applicable to Peds population
Contraindications / Cautions .
- pending FDA approval
Drug Interactions .
Overview
iberdomide
- pending FDA approval
- pending FDA approval
Safety/Monitoring .
pending FDA approval
Pharmacology .
Metabolism: pending FDA approval
Excretion: pending FDA approval
Subclass: Cereblon E3 Ligase Modulators ; Immunomodulatory IMiDs
Mechanism of Action
pending FDA approval
Formulary .
No Formulary Selected
Join Now to View Patient Handouts!
Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.
Pill Pictures
Join Now to View Pill Pictures!
Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.
Current Members: Sign In.